2-Chloro-N-(prop-2-yn-1-yl)propanamide

Catalog No.: 
ACESVY834
CAS No.: 
1016727-29-9
Molecular Formula: 
C6H8ClNO
Molecular Weight: 
145.59
2-Chloro-N-(prop-2-yn-1-yl)propanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$51.00In stockInquiry
250mg95%$71.00In stockInquiry
1g95%$196.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-N-(prop-2-yn-1-yl)propanamide
IUPAC Name2-chloro-N-(prop-2-yn-1-yl)propanamide
MDL No.MFCD09932762
Molecular FormulaC6H8ClNO
Molecular Weight145.59
SMILESCC(Cl)C(NCC#C)=O
InChI KeyHNYDVIIXHFSUMG-UHFFFAOYSA-N
Synonym2-Chloro-N-(prop-2-yn-1-yl)propanamide;Propanamide, 2-chloro-N-2-propyn-1-yl-
CAS No.1016727-29-9

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501

Synthetic Route by SureRoute

1. ACESVY834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACESVY834 route product structure diagram
    ACESVY8341016727-29-9In Stock
Inquiry

2. ACESVY834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACESVY834 route product structure diagram
    ACESVY8341016727-29-9In Stock
Inquiry

3. ACESVY834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACESVY834 route product structure diagram
    ACESVY8341016727-29-9In Stock
Inquiry

Comments (0)